Novo Nordisk Canada Inc.
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Advocacy regarding policies/issues of public health as it relates to diabetes/obesity management and prevention.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Children and Families, Education, Government Procurement, Health, Hospitals
|
|
Policy and program discussions from a broader innovative manufacturer industry perspective regarding the government's delivery of health care and/or access to appropriate/approved medications.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Finances and Budgets, Health, Hospitals
|
|
Policy and program discussions from a broader innovative manufacturer industry perspective regarding the government's delivery of health care and/or access to appropriate/approved medications.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Finances and Budgets, Health, Hospitals
|
|
Seeking public listing and reimbursement of Novo Nordisk innovative medicines on BC formularies.
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Government Procurement, Health, Hospitals
|